PATRICK THOMAS JR: Open Payments
NPI 1881836682 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,451 in 114 payments from 19 companies in 2025. Trend: 2023 $2,203 · 2024 $2,891 · 2025 $2,451
Food & beverage: $2,422Education: $29
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $426 |
| ABBVIE INC. | 23 | $323 |
| Axsome Therapeutics, Inc. | 9 | $286 |
| Neurocrine BioSciences, Inc. | 8 | $205 |
| Otsuka America Pharmaceutical, Inc. | 10 | $173 |
| Corium, LLC | 5 | $162 |
| Teva Pharmaceuticals USA, Inc. | 8 | $158 |
| E.R. Squibb & Sons, L.L.C. | 5 | $119 |
| Bausch Health US, LLC | 5 | $97 |
| Alkermes, Inc. | 4 | $89 |
Products named: CAPLYTA, VRAYLAR, Auvelity, INGREZZA, Azstarys, REXULTI, AUSTEDO XR, COBENFY.
Industry payments across TX — which companies pay providers there.
